EKSO BIONICS HOLDINGS, INC.·4

Sep 2, 5:50 PM ET

Jones Jason C 4

4 · EKSO BIONICS HOLDINGS, INC. · Filed Sep 2, 2022

Insider Transaction Report

Form 4
Period: 2022-08-31
Jones Jason C
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2022-08-31$2.31/sh5,873$13,587125,764 total
Footnotes (2)
  • [F1]Represents shares sold by the Reporting Person on August 31, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on April 11, 2022
  • [F2]The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.31 to $2.32, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Documents

1 file
  • 4
    wf-form4_166215543317641.xmlPrimary

    FORM 4